chrX-8170107-A-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_016378.3(VCX2):c.345T>A(p.Ser115Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000178 in 1,182,657 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 86 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00017 ( 0 hom., 3 hem., cov: 14)
Exomes 𝑓: 0.00018 ( 0 hom. 83 hem. )
Consequence
VCX2
NM_016378.3 missense
NM_016378.3 missense
Scores
6
11
Clinical Significance
Conservation
PhyloP100: -0.639
Genes affected
VCX2 (HGNC:18158): (variable charge X-linked 2) This gene belongs to the VCX/Y gene family, which has multiple members on both X and Y chromosomes that are expressed exclusively in male germ cells. The VCX gene cluster is polymorphic in terms of copy number; different individuals may have a different number of VCX genes. This gene contains two copies of a 30 nt tandem repeat. Deletion of a nearby member of this family was implicated in cognitive disability. [provided by RefSeq, Feb 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.1122109).
BS2
High Hemizygotes in GnomAd4 at 3 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VCX2 | NM_016378.3 | c.345T>A | p.Ser115Arg | missense_variant | 3/3 | ENST00000317103.5 | NP_057462.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VCX2 | ENST00000317103.5 | c.345T>A | p.Ser115Arg | missense_variant | 3/3 | 1 | NM_016378.3 | ENSP00000321309.4 | ||
ENSG00000285679 | ENST00000649338.1 | n.263-58228A>T | intron_variant | |||||||
ENSG00000285679 | ENST00000659022.1 | n.972-58228A>T | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.000169 AC: 15AN: 88869Hom.: 0 Cov.: 14 AF XY: 0.000183 AC XY: 3AN XY: 16387
GnomAD3 genomes
AF:
AC:
15
AN:
88869
Hom.:
Cov.:
14
AF XY:
AC XY:
3
AN XY:
16387
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000716 AC: 13AN: 181571Hom.: 0 AF XY: 0.0000741 AC XY: 5AN XY: 67493
GnomAD3 exomes
AF:
AC:
13
AN:
181571
Hom.:
AF XY:
AC XY:
5
AN XY:
67493
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000179 AC: 196AN: 1093788Hom.: 0 Cov.: 76 AF XY: 0.000229 AC XY: 83AN XY: 362320
GnomAD4 exome
AF:
AC:
196
AN:
1093788
Hom.:
Cov.:
76
AF XY:
AC XY:
83
AN XY:
362320
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000169 AC: 15AN: 88869Hom.: 0 Cov.: 14 AF XY: 0.000183 AC XY: 3AN XY: 16387
GnomAD4 genome
AF:
AC:
15
AN:
88869
Hom.:
Cov.:
14
AF XY:
AC XY:
3
AN XY:
16387
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 15, 2024 | The c.345T>A (p.S115R) alteration is located in exon 3 (coding exon 2) of the VCX2 gene. This alteration results from a T to A substitution at nucleotide position 345, causing the serine (S) at amino acid position 115 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M
MutationTaster
Benign
N
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D
REVEL
Benign
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
P
Vest4
MutPred
Loss of phosphorylation at S115 (P = 0.0059);
MVP
MPC
ClinPred
T
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at